961.18(7)(nr) (nr) Nandrolone.
961.18(7)(o) (o) 19-nor-4-androstenediol (3beta, 17beta-dihydroxyestr-4-ene; 3alpha, 17beta-dihydroxyestr-4-ene).
961.18(7)(og) (og) 19-nor-5-androstenediol (3beta, 17beta-dihydroxyestr-5-ene; 3alpha, 17beta-dihydroxyestr-5-ene).
961.18(7)(or) (or) 19-nor-4,9(10)-androstadienedione.
961.18(7)(p) (p) 19-nor-4-androstenedione (estr-4-en-3,17-dione).
961.18(7)(pg) (pg) 19-nor-5-androstenedione (estr-5-en-3,17-dione).
961.18(7)(pr) (pr) Norbolethone.
961.18(7)(q) (q) Norclostebol.
961.18(7)(qg) (qg) Norethandrolone.
961.18(7)(qr) (qr) Normethandrolone.
961.18(7)(r) (r) Oxandrolone.
961.18(7)(rg) (rg) Oxymesterone.
961.18(7)(rr) (rr) Oxymetholone.
961.18(7)(s) (s) Prostanozol.
961.18(7)(sg) (sg) Stanozolol.
961.18(7)(sr) (sr) Stenbolone.
961.18(7)(t) (t) Testolactone.
961.18(7)(tg) (tg) Testosterone.
961.18(7)(tr) (tr) Tetrahydrogestrinone.
961.18(7)(u) (u) Trenbolone.
961.18 History History: 1971 c. 219; 1981 c. 6; 1981 c. 206 ss. 32 to 40, 57; 1995 a. 448 ss. 181 to 200, 475, 476; Stats. 1995 s. 961.18; 1997 a. 220; 2009 a. 180; 2013 a. 351; ss. CSB 2.19, 2.21, 2.25, 2.29, 2.30, 2.37, 2.87, 2.89, 2.92, Wis. adm. code.
961.18 Note NOTE: See 1993-94 stats. for notes on actions by the Controlled Substances Board under s. 161.11 (1), 1993 stats.
961.19 961.19 Schedule IV tests.
961.19(1m)(1m)The controlled substances board shall add a substance to schedule IV upon finding that:
961.19(1m)(a) (a) The substance has a low potential for abuse relative to substances included in schedule III;
961.19(1m)(b) (b) The substance has currently accepted medical use in treatment in the United States; and
961.19(1m)(c) (c) Abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances included in schedule III.
961.19(2m) (2m)The controlled substances board may add a substance to schedule IV without making the findings required under sub. (1m) if the substance is controlled under schedule IV of 21 USC 812 (c) by a federal agency as the result of an international treaty, convention or protocol.
961.19 History History: 1971 c. 219; 1995 a. 448 ss. 201, 202, 477; Stats. 1995 s. 961.19.
961.20 961.20 Schedule IV. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule IV:
961.20(2) (2) Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.20(2)(a) (a) Alfaxalone;
961.20(2)(ak) (ak) Alprazolam;
961.20(2)(am) (am) Barbital;
961.20(2)(ap) (ap) Brexanolone;
961.20(2)(ar) (ar) Bromazepam;
961.20(2)(av) (av) Camazepam;
961.20(2)(ax) (ax) Carisoprodol;
961.20(2)(b) (b) Chloral betaine;
961.20(2)(c) (c) Chloral hydrate;
961.20(2)(cd) (cd) Clobazam;
961.20(2)(cg) (cg) Clotiazepam;
961.20(2)(cm) (cm) Chlordiazepoxide;
961.20(2)(cn) (cn) Clonazepam;
961.20(2)(co) (co) Cloxazolam;
961.20(2)(cp) (cp) Clorazepate;
961.20(2)(cpm) (cpm) Daridorexant;
961.20(2)(cq) (cq) Delorazepam;
961.20(2)(cr) (cr) Diazepam;
961.20(2)(cs) (cs) Dichloralphenazone;
961.20(2)(cu) (cu) Estazolam;
961.20(2)(d) (d) Ethchlorvynol;
961.20(2)(e) (e) Ethinamate;
961.20(2)(ed) (ed) Ethyl loflazepate;
961.20(2)(eg) (eg) Fludiazepam;
961.20(2)(ej) (ej) Flunitrazepam;
961.20(2)(em) (em) Flurazepam;
961.20(2)(en) (en) Fospropofol;
961.20(2)(eo) (eo) Halazepam;
961.20(2)(ep) (ep) Haloxazolam;
961.20(2)(eq) (eq) Ketazolam;
961.20(2)(eqm) (eqm) Lemborexant;
961.20(2)(er) (er) Lorazepam;
961.20(2)(es) (es) Loprazolam;
961.20(2)(eu) (eu) Lormetazepam;
961.20(2)(ew) (ew) Mebutamate;
961.20(2)(ey) (ey) Medazepam;
961.20(2)(f) (f) Methohexital;
961.20(2)(g) (g) Meprobamate;
961.20(2)(h) (h) Methylphenobarbital, which is also called mephobarbital;
961.20(2)(hg) (hg) Midazolam;
961.20(2)(hh) (hh) Nimetazepam;
961.20(2)(hj) (hj) Nitrazepam;
961.20(2)(hk) (hk) Nordiazepam;
961.20(2)(hm) (hm) Oxazepam;
961.20(2)(hr) (hr) Oxazolam;
961.20(2)(j) (j) Paraldehyde;
961.20(2)(k) (k) Petrichloral;
961.20(2)(m) (m) Phenobarbital;
961.20(2)(md) (md) Pinazepam;
961.20(2)(mg) (mg) Prazepam;
961.20(2)(mm) (mm) Quazepam;
961.20(2)(mo) (mo) Remimazolam;
961.20(2)(mr) (mr) Suvorexant;
961.20(2)(n) (n) Temazepam;
961.20(2)(ng) (ng) Tetrazepam;
961.20(2)(nm) (nm) Triazolam;
961.20(2)(o) (o) Zaleplon;
961.20(2)(p) (p) Zolpidem;
2021-22 Wisconsin Statutes updated through 2023 Wis. Act 39 and through all Supreme Court and Controlled Substances Board Orders filed before and in effect on November 29, 2023. Published and certified under s. 35.18. Changes effective after November 29, 2023, are designated by NOTES. (Published 11-29-23)